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Molecular Balance of Capillary Tube Formation
versus Regression in Wound Repair: Role of Matrix
Metalloproteinases and Their Inhibitors
George E. Davis and W. Brian Saunders
In this review, we discuss the identification of distinct matrix metalloproteinases (MMPs) and their inhibitors
that differentially control the processes of capillary tube formation (morphogenesis) versus capillary tube
regression in three-dimensional (3D) collagen matrices. This work directly relates to both granulation tissue
formation and regression during wound repair. The membrane metalloproteinase, MT1-MMP (MMP-14), is
required for endothelial cell (EC) tube formation using in vitro assays that mimic vasculogenesis or angiogenic
sprouting in 3D collagen matrices. These events are markedly blocked by small interfering RNA (siRNA)
suppression of MT1-MMP in ECs or by addition of tissue inhibitor of metalloproteinases (TIMPs)-2, -3, and -4 but
not TIMP-1. In contrast, MMP-1 and MMP-10 are strongly induced during EC tube formation to regulate the
process of tube regression (following activation by serine proteases) rather than formation. TIMP-1, which
selectively inhibits soluble MMPs, blocks tube regression by inhibiting MMP-1 and MMP-10 while having no
influence on EC tube formation. siRNA suppression of MMP-1 and MMP-10 markedly blocks tube regression
without affecting tube formation. Furthermore, we discuss that pericyte-induced stabilization of EC tube
networks in our model system appears to occur through EC-derived TIMP-2 and pericyte-derived TIMP-3 to
block both the capillary tube formation and regression pathways.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 44–56. doi:10.1038/sj.jidsymp.5650008
INTRODUCTION
The molecular and cellular events underlying wound repair
are being elucidated using a variety of models (both in vivo
and in vitro) (Clark et al., 1982; Greiling and Clark, 1997;
Smola et al., 1998; Singer and Clark, 1999; Maas-Szabowski
et al., 2001; Werner and Grose, 2003; Stark et al., 2004a, b)
and technical strategies (Grose and Werner, 2003; Yang
et al., 2003; Martin and Parkhurst, 2004; Stramer and Martin,
2005; Stramer et al., 2005). A major emphasis of many of the
studies has been the utilization of skin as a model organ and
keratinocytes as key cells to characterize these processes. An
important event during wound repair of skin is the formation
of granulation tissue, an admixture of endothelial cells (ECs),
leukocytes, fibroblasts, and provisional extracellular matrix,
which accumulates within the wound site (Clark et al., 1982;
Clark, 1985, 1993; Singer and Clark, 1999). Many studies
have led to the identification of critical molecules that
stimulate the process of angiogenesis (Conway et al., 2001;
Davis et al., 2002; Jain, 2003, 2005; Carmeliet, 2005; Davis
and Senger, 2005), a major step in wound repair, which
regulates the formation of granulation tissue (Singer and
Clark, 1999). Another important event during the healing
phase of wound repair is the regression of granulation tissue,
which involves removal of new blood vessels, provisional
extracellular matrix as well as leukocytic infiltrates (Clark,
1985, 1993; Singer and Clark, 1999). The molecular control
of this regression process is not well understood and is a
significant area of investigation for future work.
The matrix metalloproteinases (MMPs) represent an
important class of molecules that are clearly linked to the
molecular control of wound repair (Saarialho-Kere et al.,
1994; Moses et al., 1996; Kahari and Saarialho-Kere, 1997;
Madlener et al., 1998; Nwomeh et al., 1998; Bullard et al.,
1999; Wu et al., 2002, 2003; Krampert et al., 2004; Davis
and Senger, 2005). There are over 20 known members of this
family and they have diverse functions in cellular events
including wound repair, inflammation, and cancer (Parks,
1999; Parks and Shapiro, 2001; Pepper, 2001; Mott and
Werb, 2004; Parks et al., 2004; Handsley and Edwards, 2005;
Rundhaug, 2005). These enzymes proteolytically cleave
various substrates including extracellular matrix proteins,
growth factors, growth factor binding and regulatory proteins,
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and membrane receptors (Sternlicht and Werb, 2001; Mott
and Werb, 2004; Handsley and Edwards, 2005). While the
majority of MMPs are secreted, some represent transmem-
brane proteins or glycophosphatidylinositol-linked protein-
ases tethered to the cell surface (Nagase and Woessner,
1999). Recent studies indicate that some of the secreted
MMPs also become anchored to the cell surface through
binding proteins such as integrins (Dumin et al., 2001;
Stricker et al., 2001). MMPs can be specifically inhibited by a
class of inhibitors termed tissue inhibitor of metalloprotein-
ases (TIMPs) (Baker et al., 2002). There are four members of
this family, which are TIMPs 1–4. TIMP-1 appears to primarily
inhibit soluble MMPs while TIMPs-2, -3, and -4 can inhibit
both soluble and membrane-type MMPs (MT-MMPs) (Baker
et al., 2002). These inhibitors have been used as molecular
tools to help elucidate the function of different classes of
MMPs during the complex cellular and molecular events of
wound repair.
The purpose and scope of this review is to discuss the
emerging functional role of specific MMPs and their
inhibitors during granulation tissue formation and regression
using in vitro models that mimic these events. Our models
mimic either the granulation tissue formation or regression
phases of wound repair (Davis and Camarillo, 1996; Salazar
et al., 1999; Bayless et al., 2000; Bell et al., 2001; Davis
et al., 2001, 2002; Bayless and Davis, 2002; Davis and
Senger, 2005; Saunders et al., 2005), and we specifically
focus on the molecular control of EC tubular network
formation (i.e. morphogenesis) versus EC tube regression in
three-dimensional (3D) collagen matrices. Our studies reveal
that distinct MMPs are involved in these different steps and
that specific TIMPs have differential effects on these events.
ROLE OF MMPS IN CAPILLARY TUBE MORPHOGENESIS
Work over the past two decades has shown that many MMPs
are upregulated during angiogenesis and wound repair (Davis
et al., 2001, 2002; Pepper, 2001; Sternlicht and Werb, 2001;
Mott and Werb, 2004; Handsley and Edwards, 2005;
Rundhaug, 2005; Saunders et al., 2005; Stetler-Stevenson
and Seo, 2005). What has been lacking in many of the earlier
studies is a convincing role for specific MMPs in particular
events during these processes. In Figure 1, we schematically
illustrate a time course of granulation tissue formation and
regression during skin repair (Clark et al., 1982; Clark, 1993,
1985; Singer and Clark, 1999) and predict the role of specific
MMPs in these events based on our in vitro models (Davis
and Camarillo, 1996; Davis et al., 2001; Davis and Bayless,
2003; Davis and Senger, 2005; Saunders et al., 2005). Our
models show that MMPs function by either stimulating tube
formation (e.g. MT1-MMP) or stimulating tube regression
(e.g. MMP-1, MMP-10, and MMP-13), in 3D type I collagen
matrices, the predominant ECM component of skin. This
work supports the conclusion that distinct MMPs primarily
function as promorphogenic (i.e. formation) or proregression
agents (Figure 1 and later on). It remains to be determined
how these events illustrated by our in vitro models of
granulation tissue formation and regression directly relate to
the events of human or rodent skin wound repair. For
example, our studies have primarily focused on the EC
population alone and have not until recently begun to
address the potential paracrine interactions between different
cell types such as ECs and pericytes during wound repair
(Saunders et al., in preparation). However, we believe our
work illustrates new concepts that may explain previously
reported data (see below for details) and poses new testable
hypotheses.
In many prior studies, it was largely assumed that
induction of an MMP during angiogenesis, for example,
was indicative of a proangiogenic function. However, recent
work indicates that MMPs induced by ECs during angiogen-
esis have complex functions and appear to contribute to two
distinct processes, namely capillary tube formation (morpho-
genesis) and capillary tube regression (Zhu et al., 2000; Davis
et al., 2002; Davis and Senger, 2005; Handsley and Edwards,
2005; Saunders et al., 2005). Overall, the molecular basis for
the latter process is not well known but a number of stimuli
are clearly associated with the phenomenon. Such stimuli
include vascular endothelial growth factor withdrawal
(Benjamin et al., 1998, 1999), influence of thrombospondins
(Armstrong and Bornstein, 2003), influence of angiopoietin-2
(Gale et al., 2002; Thurston, 2003; Carmeliet, 2005),
treatment with microtubule disrupting agents (Bayless and
Davis, 2004), integrin antagonists (Davis et al., 2002; Davis
and Senger, 2005), biologically active extracellular matrix
fragments (i.e. matricryptins) (Davis et al., 2000; Schenk and
Quaranta, 2003), and activation of specific MMPs such as
MMP-1 and MMP-10, which destroy the ECM scaffold in
which a newly formed vascular network is embedded (Davis
et al., 2001; Saunders et al., 2005). One unresolved and
interesting question is whether the various treatments
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Figure 1. Potential role of different MMPs in granulation tissue formation
and regression in human skin wound repair. The figure is based on previously
described diagrams of granulation tissue formation and regression (Clark,
1993, 1985). The time frame on the x-axis is listed as days to weeks because
of variability in the healing time courses of different wounds and species such
as humans, mice, and pigs. The particular MMPs mentioned have been
identified to play a critical role in in vitro models of granulation tissue
formation and regression.
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mentioned above shift the proteolytic balance toward MMP-
dependent vascular regression involving MMP-1, MMP-10,
or other secreted collagenases such as human or murine
MMP-13 (see below).
Since our new data reveal an independent role for MT-
MMPs in vascular tube formation and MMP-1, MMP-10, and
MMP-13 (see below) in vascular tube regression in 3D
collagen matrices, these data should be considered in the
context of previously reported therapeutic regimens using
broad-spectrum MMP inhibitors to interfere with angiogen-
esis or cancer progression (Coussens et al., 2002; Egeblad and
Werb, 2002). There was much disappointment in that these
MMP inhibitors had little clinical efficacy and for the most
part did not work as expected (Coussens et al., 2002; Egeblad
and Werb, 2002). Our data suggest one possible reason for
this failure to inhibit angiogenesis, since the added broad-
spectrum inhibitors likely block both tube formation as well
as tube regression in these in vivo contexts. Interference with
the normal process of tube regression would be expected to
increase vascularity within tissues (i.e. an unexpected
consequence of these therapies). Thus, such therapeutic
regimens were not specific enough to target individual
molecules required for either capillary tube formation versus
regression. Our new work raises the possibility that targeting
individual MMPs or TIMPs might allow for a shift of the
balance of vascularity toward more or less vessels (i.e. to
independently regulate capillary tube formation versus
regression) depending on the particular therapeutic applica-
tion. Importantly, much continued work is required to
identify the specific MMPs, TIMPs, or other molecules that
regulate these distinct events. The work discussed below
describes our recent attempts to delineate the role of specific
MMPs and TIMPs in the molecular control of human capillary
tube formation versus regression in 3D ECM environments.
CRITICAL ROLE FOR MEMBRANE-TYPE
METALLOPROTEINASES IN VASCULAR TUBE
FORMATION IN 3D COLLAGEN MATRICES
My laboratory has focused much attention on the develop-
ment of models of capillary tube morphogenesis in 3D
extracellular matrices including type I collagen or fibrin
(Davis and Camarillo, 1996; Bayless et al., 2000; Davis et al.,
2002) (Figure 2). This work has allowed us to identify critical
regulatory molecules that regulate tube formation including
integrins (Davis and Camarillo, 1996; Bayless et al., 2000;
Davis et al., 2002; Davis and Bayless, 2003; Davis and
Senger, 2005), cytoskeletal regulators such as Cdc42 and
Rac1 (Bayless and Davis, 2002; Davis and Bayless, 2003;
Davis and Senger, 2005), and provisional basement mem-
brane matrix components such as collagen type IV (Bell et al.,
2001; Davis and Senger, 2005). The systems are excellent
models to study the process of lumen formation (Davis and
Camarillo, 1996; Bayless and Davis, 2002; Davis et al., 2002;
Davis and Bayless, 2003) in real-time where individual cells
form 3D networks of EC-lined tubes within a 48–72 hour
period. A time-lapse study is shown in Figure 2, whereby a
group of ECs is observed to form a network of tubes over a
period of 48 hours (Figure 2a). In Figure 2b, individual ECs
are examined by electron microscopy to form a matrix-free
lumenal space over this time frame. Importantly, the addition
of metalloproteinase inhibitors such as TIMP-3, which blocks
membrane-type MMPs, completely blocks the ability of ECs
to form tubular networks in 3D collagen matrices (Figure 2c).
In contrast, TIMP-1, an inhibitor of soluble but not
membrane-type MMPs, does not block capillary tubular
network formation (Figure 2c). In this assay system, ECs are
suspended as individual cells in collagen matrices, which
mimics the process of vasculogenesis (Davis et al., 2002). The
influence of TIMPs is observed in a different assay system,
which mimics the process of angiogenesis (Figure 3a). In this
assay, ECs invade and undergo tubular morphogenesis by
sprouting from a pre-existing monolayer of ECs on the surface
of a collagen matrix (Bayless and Davis, 2003). As shown in
Figure 3a, the addition of recombinant TIMPs including either
TIMP-2 or TIMP-3 markedly block invasion and tube
formation. As in the vasculogenic assay, TIMP-1 has no
effect when compared to control. TIMP-2 and TIMP-3 have in
common the ability to block the cell surface expressed MT-
MMP family of proteinases, while TIMP-1 does not block
these enzymes. Chemical inhibitors such as GM6001 are also
known to interfere with the activity of MT-MMPs. EC tubular
morphogenesis is completely blocked by GM6001 addition
in either the ‘‘vasculogenic’’ or ‘‘angiogenic’’ systems (not
shown). A newly developed variation of these assay systems
is shown in Figure 3b. In this system, human ECs are
preaggregated for 2 hours prior to attaching them to collagen-
coated plastic surfaces and overlaying them with a 3D
collagen matrix. In this system, EC–EC aggregates of about 10
cells form dramatic lumenal structures and undergo sprouting
Control
TIMP-1
TIMP-3
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Figure 2. Formation of human capillary tubes in 3D collagen matrices.
Human ECs are placed in collagen matrices as described (Davis and
Camarillo, 1996) and were photographed using time-lapse microscopy
(Saunders et al., 2005), were processed for electron microscopy or were
treated with purified TIMP-1 or TIMP-3 (5 mg/ml) (C). (a) Upper panel –2 hours
culture; lower panel – 48 hours culture of same field; bar¼ 100mm. (b) Upper
panel – 2 hours culture; lower panel – 48 hours culture; bar¼ 10mm.
(c) Arrows indicate capillary tube structures; arrowheads indicate ECs with
fine processes with no lumenal structures; bar¼ 100mm.
46 Journal of Investigative Dermatology Symposium Proceedings (2006), Volume 11
GE Davis and WB Saunders
Role of MMPs in EC Tube Formation versus Regression
over a 24 hour period (Figure 3b, left panel). In the right panel
of Figure 3b, aggregates treated with GM6001 are shown at
24 hours and are of similar appearance to the starting
aggregates (open arrowheads) except that fine EC processes
are observed projecting from the aggregates. Thus, addition
of GM6001 completely interferes with the ability of the
aggregates to undergo tube formation and lumenal morpho-
genesis. Interestingly, these EC-derived fine processes can
project into the collagen matrix even with inhibition of MT-
MMPs suggesting that these enzymes are not required for EC
process extension in 3D collagen matrices. Overall, these
data strongly indicate the MT-MMPs are critical regulators of
human capillary tubular morphogenesis in 3D collagen
matrices. Previously, we showed that invasion and tubular
morphogenesis in fibrin matrices was similarly blocked by
proteinase inhibitors that block MT-MMPs (Bayless and
Davis, 2003). In support of our studies, other work has
shown the importance of MT-MMPs in vascular morphogene-
sis (Hotary et al., 2000; Davis et al., 2002; Lafleur et al.,
2002; Bayless and Davis, 2003; Chun et al., 2004; Davis and
Senger, 2005).
MT1-MMP IS REQUIRED FOR HUMAN CAPILLARY TUBE
FORMATION IN 3D COLLAGEN MATRICES
To address the specific role of individual surface metallopro-
teinases in our vasculogenic and angiogenic morphogenic
systems, we suppressed expression of various MMPs in small
interfering RNA (siRNA) experiments. In a recent report, we
have successfully adapted siRNA technology for use in our
3D systems whereby ECs can be pretreated with siRNAs and
then placed in 3D tube morphogenesis and regression assays
(Saunders et al., 2005). We have considerable experience
with this technique in our systems and have observed only a
small number of siRNAs that have a profound blocking
influence on EC tube morphogenesis. One such siRNA is
directed to the a2 integrin subunit (Mareth et al., in
preparation), a collagen receptor component known to
regulate tube morphogenesis in these models (Davis and
Camarillo, 1996; Davis and Senger, 2005). In Figure 4, we
show that an siRNA directed to MT1-MMP markedly blocks
EC tube formation, lumen development, and invasion of ECs
in vasculogenic or angiogenic assays. We have documented
that MT1-MMP protein expression is strongly suppressed by
this treatment (Saunders et al., in preparation). Importantly,
an MT3-MMP siRNA and a control luciferase siRNA have no
effect in either assay system (Figure 4). An examination of the
MT1-MMP siRNA-treated ECs in the middle right panel of
Figure 4 reveals that the ECs are sending out fine processes
just like the processes observed in the GM6001 treated cells
in Figure 3b (right panel). These processes are also clearly
observed in the TIMP-3-blocked ECs in Figure 2c (lower right
panel). Essentially identical results are observed when EC
cultures are treated with either purified TIMP-2 or TIMP-4
(Saunders et al., in preparation). It should also be noted that
EC lumen development is completely inhibited by these
treatments (Saunders et al., in preparation). These data
strongly indicate that TIMPs-2-4 and GM6001 are likely
targeting MT1-MMP since ECs treated with MT1-MMP siRNA
strongly recapitulate the phenotype observed following
treatment with TIMPs-2-4 or GM6001. Overall, our data
and the work of others indicate a critical role for MT1-MMP
in EC tube assembly and network formation in 3D ECM
environments.
ROLE OF MMPS IN CAPILLARY TUBE REGRESSION
EVENTS
Capillary tube regression is a well known response during
wound repair (Clark, 1993, 1985) (see Figure 1), hyaloid
vessel regression in the developing retina (Saint-Geniez and
D’Amore, 2004), and the menstrual cycle in both the ovary
and uterus in humans and selectively in the ovary in a variety
of other species (Marbaix et al., 1995, 1996; Galant et al.,
2004). In humans, there is ample evidence for hormonally
regulated expression of MMPs, such as MMP-1, during the
menstrual cycle, which coincidently peak with vascular
Control
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Figure 3. Membrane-type MMPs are required for EC invasion and tube
morphogenesis in 3D collagen matrices. Human ECs are placed onto the
surface of collagen matrices as described which contain 1 mM sphingosine-1-
phosphate (Bayless and Davis, 2003). Cultures were treated with purified
TIMPs each at 5mg/ml and the cultures were fixed and processed for thin
plastic sectioning after 48 hours. (a) Arrows indicate EC monolayer; open
arrowhead indicates invading EC sprouts with open lumenal structures; closed
arrowhead indicates invading ECs with no lumenal structures. Bar¼40 mm.
(b) ECs were preaggregated in solution (1 107 cells/ml) at 371C in serum-free
medium for 2 hours and were then gently added to collagen coated plastic
wells (50 mg/ml collagen type I in phosphate-buffered saline) in 24-well plates
for 20 minutes. Unattached aggregates were washed off and the remaining
attached aggregates were covered with collagen type I gel which is
polymerized at 3.75 mg/ml as described (Davis and Camarillo, 1996). Culture
media was prepared as described (Davis and Camarillo, 1996) and contained
GM6001 (5 mM) or DMSO carrier control. Cultures were fixed and
photographed after 24 hours of culture. Arrows indicate multicellular EC
lumenal structures while arrowheads indicate EC–EC aggregates with fine
process extensions but without lumen structures. Bar¼100 mm.
www.jidonline.org 47
GE Davis and WB Saunders
Role of MMPs in EC Tube Formation versus Regression
regression and the onset of menses (Marbaix et al., 1995,
1996). These reports argue for a potential role for MMP-1 as a
vascular regression factor in humans. Also, MMP-1 was
demonstrated to be present in or directly adjacent to blood
vessels within granulation tissue in both human and pig skin
wounds, and thus was observed to be present in a location
and time that is consistent with a role in vascular regression
during wound repair (Stricklin et al., 1993, 1994; Stricklin
and Nanney, 1994).
We have developed a series of models of capillary tube
regression, which mimic the regression phase of granulation
tissue removal during wound repair (Figure 1). Interestingly,
we have clear evidence for a role of MMP-1 (collagenase-1)
and MMP-10 (stromelysin-2) as vascular regression factors
during these events (Davis et al., 2001; Saunders et al., 2005).
Furthermore, both MMP-1 and MMP-10 are expressed by
human ECs derived from endometrial tissue (Krikun et al.,
2005), which supports our conclusions and suggests that they
could participate in vascular regression events of endometrial
vessels during the shedding phase of the menstrual cycle.
Both pro-MMP-1 and pro-MMP-10 are markedly induced
during capillary tubular morphogenesis in our serum-free
model of vascular morphogenesis (Figure 5) (Davis et al.,
2001; Saunders et al., 2005). We have found no evidence
that these MMP proenzymes are activated during morpho-
genesis in either the vasculogenic or angiogenic models,
despite a marked induction of these two proteins. Western
blots show a marked predominance of the proenzyme forms
of both MMP-1 and MMP-10 (Figure 5). This result is
obtained using our standard assay conditions (i.e. serum-free
conditions), which were used to demonstrate a role for
membrane-type metalloproteinases in EC tube morphogen-
esis as illustrated in earlier Figures 2–4 and our previous
publications (Davis and Camarillo, 1996; Davis et al., 2001;
Saunders et al., 2005). These data suggest that activated forms
of MMP-1 and MMP-10 are not necessary for EC tube
formation or invasion. Also, addition of TIMP-1 or alpha2-
macroglobulin, which represent strong inhibitors of both of
the activated forms of these enzymes, has no influence on
tube formation (see Figures 2 and 3).
MMP-1 AND MMP-10 ARE VASCULAR REGRESSION
FACTORS FOR HUMAN CAPILLARY TUBE NETWORKS
We have reported in several studies that MMP-1 and MMP-10
are vascular regression factors in our granulation tissue-like
assay system (Davis et al., 2001; Saunders et al., 2005). When
pro-MMP-1 was activated by the addition of plasminogen
"Angiogenic sprouting
assay" "Vasculogenic assay"
Luciferase
MT1-MMP
MT3-MMP
siRNA
100 m
100 m
100 m
Figure 4. MT1-MMP is required for human endothelial capillary tube
formation in 3D collagen matrices. ECs were transfected with MT1-MMP,
MT3-MMP, or luciferase (control) siRNA duplexes using methods previously
described (Saunders et al., 2005) prior to placement on the surface of 3D
collagen gels in the ‘‘angiogenic sprouting assay’’ (left panels) or suspended
within 3D collagen gels in the ‘‘vasculogenic assay’’ (right panels). Cultures
were allowed to undergo capillary tube formation for 24 hours prior to
fixation, staining with 0.1% toluidine blue, and photography at original
magnification  10 (left panels) or  20 (right panels). (a) In the angiogenic
assay, ECs from a confluent monolayer (shown in background) are induced to
form sprouts into the 3D collagen matrix, which over time form lumenal
structures (capillary tube morphogenesis). ECs transfected with luciferase or
MT3-MMP siRNA undergo normal tube formation, while MT1-MMP treated
ECs are unable to undergo tube formation. Bar¼ 50mm. (b) In the
vasculogenic assay, ECs suspended as individual cells throughout the 3D
collagen gel form pinocytic vacuoles, which coalesce into lumenal structures
over time. Eventually, individual lumen-containing cells unite to form
multi-cellular 3D tubular networks. As in the angiogenic assay, ECs
transfected with luciferase or MT3-MMP siRNA undergo normal vasculo-
genesis, while MT1-MMP treated ECs are unable to undergo morphogenesis;
however, these cells are capable of forming sprouts (arrowheads), similar to
treatment with TIMP-2,-3, or GM6001. Bar¼ 100mm.
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0 84 24 48 7212
48 Hour 1 8 24 4840 56 64 72 Hour
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Figure 5. Human endothelial cells induce proMMP-1 and proMMP-10 in 3D
collagen matrices to regulate capillary tube regression, and not capillary
tube formation (morphogenesis). ECs were suspended as described in 3D
collagen matrices (Davis and Camarillo, 1996) and allowed to undergo
capillary tube formation (morphogenesis) in the absence of serine proteases in
serum-free media. (a) At the indicated time points, conditioned media were
collected and cultures were extracted for reverse transcriptase-PCR or
Western blot analysis. (b) Alternatively, cultures were fixed in 3%
glutaraldehyde and stained with 0.1% toluidine blue for photography,
bar¼ 50 mm. As demonstrated, ECs induce both proMMP-1 mRNA and
protein zymogen. Additionally, ECs induce proMMP-10 as detected via
Western blot. (b) In the absence of serine proteases, MMP-1 and MMP-10
remain as zymogens. Importantly, ECs form capillary tubular networks over
72 hours in the absence of serine proteases or activated MMP-1 and MMP-10.
Arrows indicate the borders of an EC sprout and tube structure.
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(converted to plasmin by EC-derived plasminogen activators),
there was a marked tube regression response coincident with
degradation of the type I collagen matrix and collagen gel
contraction, which is a convenient measure of the regression
event (Davis et al., 2001; Saunders et al., 2005). Also, there
was a time-dependent EC apoptotic response with pro-
caspase 3 activation and cleavage of a known caspase
substrate, gelsolin (an induced gene during tube morphogen-
esis) (Salazar et al., 1999) following the morphologic tube
regression response (Davis et al., 2001). Interestingly, there is
a known temporal overlap of wound contraction with
granulation tissue regression during human skin wound
repair in vivo, suggesting the possibility that ECs could
participate directly in wound contraction along with myo-
fibroblasts (Clark, 1993, 1985). During tube regression it is
evident that ECs exert considerable mechanical force on the
proteolyzed collagen matrix, which directly contributes to
the collapse of EC-lined tubes (Davis et al., 2001; Saunders
et al., 2005). Importantly, the addition of plasminogen or
plasmin, which induces the activation of MMP-1 and MMP-
10, has no influence of capillary tube formation, which
proceeds normally even with activation of these soluble
MMPs. Thus, our data suggest that MMP-1 and MMP-10 act
as EC tube regression agents and do not appear to play a role
in EC tube formation.
Similar types of EC-contractile phenomena occur during
EC tube network collapse following the addition of micro-
tubule disrupting agents (Bayless and Davis, 2004). The
MMP-dependent and microtubule-depolymerizing mechani-
sms of tube collapse that we are investigating appear to occur
through distinct but related processes. For example, it is clear
that the mechanical strength of the ECM resists the normal
tendency of EC tube networks to collapse due to mechanical
forces generated by the ECs on the 3D ECM (Davis et al.,
2002; Davis and Senger, 2005). When the integrity of this
ECM scaffold is compromised by proteolysis through MMP-1
and MMP-10 activation, this scaffold can no longer resist
these forces and the tube structures collapse (Davis et al.,
2001; Saunders et al., 2005). This is likely to occur during
wound repair processes whereby ECM remodeling and
removal occurs coincident with regression of granulation
tissue and wound contraction (Clark 1993, 1985). Impor-
tantly, in the case of MMP-dependent tube regression, we
have shown that these tube collapse events occur prior to the
eventual collagen gel contraction event (Saunders et al.,
2005). In contrast, microtubule disrupting agents rapidly
collapse tubes because ECs appear to lose contact with the
collagen ECM in a manner which depends on the small
GTPase, RhoA (Bayless and Davis, 2004). In this case, the
ECM scaffold is not significantly changed but the connection
of the ECs with the collagen ECM is clearly altered to direct
the collapse event. Thus, alterations of the ECM scaffold or
the underlying and connected EC cytoskeleton (downstream
of integrins) results in similar types of morphologic tube
collapse which in both cases leads to later EC apoptosis
(Davis et al., 2001; Bayless and Davis, 2004). Both of our
models result in the development of apoptosis, which is a
characteristic feature of regressing tissues in vivo (Dimmeler
and Zeiher, 2000; Zuzarte-Luis and Hurle, 2005; Baffert
et al., 2006; Simian et al., 2006).
To further delineate the key features and characteristics of
our MMP-1-dependent regression system, we investigated
and reported that plasminogen/plasmin was only one serine
protease that could activate MMP-1 and that six additional
serine proteases were shown to similarly activate pro-MMP-1
to induce capillary tube regression (Saunders et al., 2005).
The most important of these is likely plasma prekallikrein
since like plasminogen, it is strongly activated by the EC cell
surface (Colman, 1999; Rojkjaer and Schmaier, 1999;
Schmaier, 2000). Plasma kallikrein was found to activate
pro-MMP-1 and to markedly induce capillary tube regression
(Figure 6a). Interestingly, recent studies indicate that plas-
minogen and plasma kallikrein can synergistically act to
facilitate mammary gland regression following the cessation
of lactation (Selvarajan et al., 2001). We have also found that
a combination of plasminogen and plasma kallikrein induces
a more rapid capillary tube regression response than either
protease alone. Thus, MMPs and their activating serine
proteinases are not only implicated in capillary tube
regression, but also another type of tissue regression that
occurs during mammary gland involution (Green and Lund,
2005).
To further characterize these systems, we recently develop-
ed a 384 well assay system that facilitates our ability to
quantitate the capillary tube regression response, which is
assessed using collagen gel contraction over time (Saunders
et al., 2005). This assay system is illustrated in Figure 6b
whereby a dose response of plasmin is shown to directly affect
the timing of the vascular regression response. Increasing
concentrations of plasmin are shown to increase the speed by
which tube regression occurs. The regression response also
directly correlates with proenzyme activation of both MMP-1
and MMP-10 (Figure 6b, lower panel). Like MMP-1, MMP-10
was similarly activated by all seven of the serine proteases that
induced capillary tube regression (Saunders et al., 2005).
The MMP-1 and MMP-10-dependent capillary tube
regression pathway can be inhibited by multiple TIMPs
including TIMP-1 (Davis et al., 2001; Saunders et al., 2005).
Thus, TIMP-1 selectively blocks capillary tube regression
without blocking EC tube morphogenesis (see Figures 2 and
3), indicating that soluble MMPs such as MMP-1 and -10 are
regulating regression, while membrane-bound MMPs such as
MT1-MMP are required for morphogenesis. Interestingly, the
tumor microenvironment has been described as a ‘‘wound
that does not heal’’ (Dvorak, 1986) and many tumor cell
types overexpress TIMP-1 (Wurtz et al., 2005). Thus, TIMP-1
can interfere with capillary tube regression without affecting
tube formation, which might result in a net increase in vessel
density. Many abnormal vessels in a tumor wound bed,
which in a normal context would undergo regression,
may not regress due to elevated levels of tumor-derived
TIMP-1. Consistent with such conclusions are reports
showing that TIMP-1 knockout animals show decreased
vessel density during angiogenesis, while the opposite is true
of TIMP-1 overexpressing transgenic mice (Yamada et al.,
2001).
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siRNA SUPPRESSION OF MMP-1 AND MMP-10
MARKEDLY BLOCKS CAPILLARY TUBE REGRESSION
To further address the function and importance of both MMP-
1 and MMP-10 in the tube regression response, we performed
siRNA knockdown experiments (Saunders et al., 2005). These
experiments demonstrate a selective ability of MMP-1
(Figure 7) and MMP-10 to strongly regulate capillary tube
regression while siRNAs to MMP-2, MMP-9, and MMP-3 had
no effect (Saunders et al., 2005). In addition, we find no
evidence for protein expression of either pro-MMP-13 or pro-
MMP-8 (i.e. other known interstitial collagenases) by ECs
during tube formation (Saunders and Davis, unpublished
observations).
Suppression of MMP-1 and MMP-10 protein expression by
siRNA treatment does not influence EC tube formation as
illustrated for MMP-1 in Figure 7b and c. In contrast, a
marked delay in EC tube regression resulted from the
knockdown of MMP-1 protein (Figure 7a). Furthermore, we
developed adenoviral vectors producing either MMP-1 or
MMP-10. Increased expression of both MMP-1 and MMP-10
strongly induces capillary tube regression without having any
influence on tube formation (Saunders et al., 2005). The
mechanism of action of MMP-10 in this context appears to be
in part the facilitation of MMP-1 activation since it is known
that stromelysins (e.g. MMP-3 or MMP-10) and serine
proteases such as plasmin can act together to create a
‘‘superactive’’ MMP-1 molecule (Suzuki et al., 1990).
Western blot analysis shows that increased MMP-1 acti-
vation occurs with increased MMP-10 expression while a
strong decrease in MMP-1 activation occurs with siRNA
knockdown of MMP-10 (Saunders et al., 2005). Overall, our
data indicate that MMP-1 and MMP-10 synergize together
to regulate capillary tube regression responses (Saunders
et al., 2005). Furthermore, MMP-1 targets collagen matrices
while MMP-10 (and the related MMP-3) can target base-
ment membrane matrices (Bejarano et al., 1988), which
represent the two key ECM scaffolds that are responsible for
formation and maintenance of capillary tubular networks
(Vernon and Sage, 1995; Davis et al., 2002; Davis and
Senger, 2005).
MURINE MMP-13 CAN INDUCE CAPILLARY TUBE
REGRESSION
In the mouse genome, there is no homologue for MMP-1
which shows a similar expression pattern to that of human
MMP-1 mRNA or protein. Many studies have focused on
murine MMP-13 (Henriet et al., 1992), which has interstitial
collagenase activity (Wu et al., 2002, 2003) and may
substitute for the collagenase activity of human MMP-1.
Interestingly, murine MMP-13 is induced in a temporal time
frame during mouse skin wound repair in a manner consistent
with a role in regression of granulation tissue (i.e. vascular
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Figure 6. Serine proteinase induced activation of EC-derived MMP-1 and MMP-10 results in capillary tubular network regression and collagen gel
contraction. (a) ECs were suspended in collagen matrices, plated in 96-well tissue culture plates (4.5 mm diameter), and cultured in the presence of plasma
kallikrein at 1mg/ml. Serial time-lapse photography of a single well was performed at the indicated time points (in hours) during the capillary tube regression and
collagen gel contraction process (Saunders et al., 2005). Bar¼500 mm. (b) ECs were suspended in a quantifiable 384 micro-well regression assay as previously
described. ECs were cultured in the absence (0) or in the presence of increasing concentrations of plasmin (mg/ml). Cultures were monitored every 4 hours for
capillary tube regression and gel contraction, and percentage gel contraction was recorded for each dose of plasmin at each time point. Data are reported as the
percent collagen gel contraction over time (7SD). At 72 hours, conditioned media were collected and analyzed for MMP-1 and MMP-10 expression and
activation via Western blot. Capillary tube regression and collagen gel contraction directly correlated with the activation of MMP-1 and MMP-10 from latent
(arrows) to activated (arrowheads) forms on Western blots.
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regression) as well as in collagen remodeling (Wu et al.,
2002, 2003). Its expression pattern does not correlate with a
time course involving the formation of new blood vessels in
this repair response and significantly lags behind collagen
type I gene synthesis (Wu et al., 2003). Importantly, studies in
mice, pig, and human tissues during in vivo wound repair
(Stricklin et al., 1993, 1994; Stricklin and Nanney, 1994; Wu
et al., 2002, 2003) are very consistent with our conclusions
shown in Figure 1 that MMP-13 and MMP-1 are expressed in
a temporal time course that is consistent with a role in the
regression phase of granulation tissue rather than its forma-
tion. Both MMP-13 and MMP-1 are found within granulation
tissue and are expressed within the wall or are present around
vessels in these settings (Stricklin et al., 1993, 1994; Stricklin
and Nanney, 1994; Vaalamo et al., 1997; Wu et al., 2002,
2003). In support of such conclusions are new data from our
laboratory showing that adenoviral-induced production of
MMP-1 in vivo during vascular endothelial growth factor-
induced angiogenesis in the chick chorioallantoic membrane
results in vascular collapse and regression of these new
vessels (Saunders et al., in preparation). These previous
studies, our in vitro models, and our new in vivo models are
all strongly supportive of the conclusion that MMP-1, MMP-
10, and MMP-13 play a role as vascular regression factors in
vivo and in vitro.
To experimentally address the possibility that mouse or
human MMP-13 may be capable of inducing capillary tube
regression in our models, we developed recombinant
adenoviral vectors that express these MMP-13 proteins as
well as human MMP-1. In Figure 8a, data are presented
showing that increased MMP-1 expression in ECs strongly
accelerates the capillary tube regression response when
serine proteases such as plasminogen are added. Plasmino-
gen is converted by ECs through plasminogen activators to
plasmin, which then directly activates pro-MMP-1 as well as
other pro-MMPs such as MMP-10 and MMP-13 (Davis et al.,
2001; Pepper, 2001; Saunders et al., 2005). The timing of this
response directly correlates with the amount of plasminogen
added and directly correlates with activation of pro-MMP-1
(Figure 8a). In a similar manner, murine MMP-13, when
expressed in human ECs, strongly regulates capillary tube
regression in a manner dependent on the concentration of
plasminogen (Figure 8b). The regression response following
mouse MMP-13 expression in human ECs is clearly acceler-
ated by the presence of plasminogen (Figure 8b, left panel
time course). However, expression of murine MMP-13 in
human ECs is distinct from MMP-1 in that it eventually will
cause a regression response even in the absence of added
plasminogen (Figure 8b), suggesting that there is another
mechanism for activation of pro-MMP-13 independent of
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added plasminogen. Also, human MMP-13 (Freije et al.,
1994) acts just like murine MMP-13 in our system and will
induce capillary tube regression following its expression
(Saunders and Davis, unpublished observations). Interest-
ingly, MMP-13 is strongly expressed in human granulation
tissue (Vaalamo et al., 1997) and thus could participate in the
regression response that we describe. One possibility is that
MT-MMPs may regulate pro-MMP-13 activation during EC
morphogenesis since they have been reported to perform
such a function for MMP-13 but not MMP-1 (Murphy et al.,
1999). In Figure 8a and b, panels are shown illustrating the
influence of EC conditioned media on the level of collage-
nase activity using a microplate fluorescence collagenase
activity assay (Saunders et al., 2005). EC conditioned media
alone has minimal collagenase activity (Saunders et al., 2005)
and increased expression of either human MMP-1 or murine
MMP-13 strongly induces collagenase activity in conditioned
medium. This detectable collagenase activity directly corre-
lates with the capillary tube regression response shown in
Figure 8a and b. Our adenoviral vectors also induce the co-
expression of green fluorescent protein in ECs and a time-
lapse regression experiment with increased expression of
MMP-1 is shown following the addition of plasminogen
illustrating collagen gel contraction of a population of green
fluorescent protein expressing ECs (Figure 8c). This work
shows that murine MMP-13 can substitute for human
MMP-1 in our regression assay system and suggests that it
may be capable of inducing capillary tube regression
responses during rodent wound repair events (Wu et al.,
2002, 2003).
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Figure 8. Expression of human MMP-1 or murine MMP-13 in ECs via adenoviral mediated gene transfer leads to accelerated capillary tube regression and
collagen gel contraction in 3D collagen matrices. ECs were induced to express GFP, human MMP-1, or murine MMP-13 prior to suspension in the 384
micro-well regression assay as described (Saunders et al., 2005). ECs were cultured in the absence or presence of varying amounts of plasminogen (mg/ml) and
cultures were monitored every 4 hours for capillary tube regression and collagen gel contraction. At 48 hours, conditioned media were collected and
analyzed via Western blot for MMP-1 or MMP-13 expression and activation, as well as total collagenase activity via a fluorescent DQ collagen substrate assay
performed as described (Saunders et al., 2005). (a) ECs expressing increased levels of MMP-1 underwent plasminogen-dependent regression that correlated with
activation of MMP-1 on Western blot and elevated collagenase activity in conditioned media. MMP-1 did not induce regression in the absence of
plasminogen. (b) ECs expressing murine MMP-13 underwent plasminogen dependent-regression in a manner similar to MMP-1; however, ECs expressing
MMP-13 also underwent regression in the absence of plasminogen, a phenomenon unique to both murine and human MMP-13 (data not shown). (c) ECs
suspended in the 384 micro-well regression assay (from panel A) were photographed under fluorescence at original magnification 4 at the indicated
time points to illustrate the capillary tube regression and gel contraction response which is analogous to wound contraction in the latter stages of wound
healing. Bar¼ 1.0 mm.
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PERICYTES CAN BLOCK MMP-1 AND
MMP-10-DEPENDENT CAPILLARY TUBE REGRESSION
RESPONSES
EC–pericyte interactions are well known to stabilize newly
formed capillary tube networks during development and
angiogenic responses (Armulik et al., 2005; von Tell et al.,
2006). To address whether pericytes might influence MMP-1
and MMP-10-dependent capillary tube regression responses,
we developed a co-culture model whereby bovine retinal
pericytes are co-cultured with human ECs during the
capillary tube regression response (Saunders et al., in
preparation). Under these conditions, it is clear that the
addition of pericytes strongly inhibits EC MMP-1 and -10
dependent regression. In this system, pericyte addition to
30% of the total EC concentration results in complete
blockade of MMP-1 and MMP-10 activation in response to
plasmin or plasma kallikrein. Using siRNA technology
approaches, we have identified that EC-derived TIMP-2 and
pericyte-derived TIMP-3 are together responsible for the
EC–pericyte co-culture inhibition of tube regression in our
model (Saunders et al., in preparation). Pericyte recruitment
markedly blocks this EC-derived proteolytic activity by
delivering TIMP-3 (which is strongly induced by EC–pericyte
interactions) (Saunders et al., in preparation). These new data
provide additional support for the MMP-1 and MMP-10
model of tube regression and may provide mechanistic
insight into how pericytes stabilize newly formed EC-lined
tubes. Importantly, this same combination of inhibitors,
TIMP-2 (Stetler-Stevenson and Seo, 2005) and TIMP-3
(Vranka et al., 1997; Lafleur et al., 2001), also strongly
blocks EC tube formation (see Figures 2 and 3) through
inhibition of MT1-MMP (Figure 4), which is also necessary to
regulate capillary tube stabilization. Thus, our data suggest
that specific EC or pericyte-derived MMPs or inhibitors
regulate a proteolytic molecular balance, which either drives
EC tube formation (MT1-MMP), regression (MMP-1 and
MMP-10 and serine proteases), or eventual tube stabilization
(delivery of TIMP-2 and TIMP-3 following pericyte recruit-
ment) by inhibition of both the morphogenic and regression
pathways (Figure 9). Key EC molecular changes that
characterize the development of capillary tube stabilization
include cessation of tube morphogenesis, assembly of base-
ment membrane matrices, development of EC apical–basal
polarity, suppression of EC proliferation, blockade of
capillary tube regression events, and establishment of EC
quiescence (Davis et al., 2002; Davis and Senger, 2005).
Considerable further study is necessary here to investigate
how factors such as transforming growth factor (TGF)-b,
angiopoietins and HB-EGF affect these stabilizing events
since the levels of these factors are modulated and regulated
by EC–pericyte interactions and play an important role in
vascular stabilization (Hirschi et al., 1998, 1999; Jain, 2003;
Thurston, 2003; Bjarnegard et al., 2004; Leask and Abraham,
2004; Armulik et al., 2005; Davis and Senger, 2005; von Tell
et al., 2006). Preliminary experiments suggest that TGF-b
enhances vascular stabilization in our systems by partially
inhibiting MMP-1 and MMP-10-dependent capillary tube
regression when ECs are cultured alone and enhancing the
ability of pericytes to stabilize tubes undergoing MMP-
dependent regression in EC–pericyte cocultures (Davis
et al., unpublished observations).
Other EC–mesenchymal cell interactions which are
relevant during wound repair responses include EC interac-
tions with fibroblasts. Recent studies have indicated that
fibroblasts deliver factors to ECs, which strongly affect the
ability of ECs to form tubes in a key provisional wound repair
ECM such as fibrin (Nakatsu et al., 2003). Since fibroblasts
preceed ECs invasion into fibrin matrices in a wound
environment (Greiling and Clark, 1997), it is possible that
ECM modifications delivered by fibroblasts or growth factors
MT-MMPs
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Figure 9. Schematic diagram illustrating the role of MMPs and TIMPs in capillary tube formation versus regression in wound repair. S1P indicates
sphingosine-1-phosphate, a regulator of EC tube morphogenesis (Bayless and Davis, 2003); PAI-1 indicates plasminogen activator inhibitor-1, an important
inhibitor of EC plasminogen activators (Pepper, 2001) and inhibitor of MMP-1-dependent tube regression dependent on plasminogen (Davis et al., 2001);
TFPI-2 indicates tissue factor pathway inhibitor-2, an induced serine protease inhibitor during tube formation (Bell et al., 2001).
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may be necessary to stimulate EC tube morphogenesis under
these conditions (Bayless et al., 2000; Lafleur et al., 2002;
Nakatsu et al., 2003). Further work will be necessary to
identify the relevant fibroblast-derived factors that are
responsible for the facilitation of EC tube morphogenesis
during early wound healing events (Nakatsu et al., 2003).
CONCLUSION
In this review, we have discussed the critical role of specific
MMPs in either capillary tube formation or regression. We
have developed in vitro models that mimic granulation tissue
formation versus regression by using human ECs suspended
in 3D collagen matrices. In these models, we have shown
that MT1-MMP is required for tube formation while the
soluble MMPs, MMP-1, and MMP-10, are required for tube
regression. siRNA suppression of MT1-MMP blocks tube
formation, while siRNA suppression of MMP-1 and MMP-10
selectively blocks tube regression without affecting tube
formation. Interestingly, TIMP-1 has no ability to block tube
formation while it strongly inhibits tube regression consistent
with its known ability to block soluble MMPs such as MMP-1
and MMP-10 while being unable to block membrane MMPs
such as MT1-MMP. In contrast, TIMPs-2 and -3 can block
both tube formation as well as regression in our model
systems. These latter two TIMPs may have important roles in
tube stabilization events and in fact EC–pericyte interactions
appear to regulate the delivery or presentation of TIMP-2 and
TIMP-3 to facilitate tube stabilization in our model. This
occurs due to suppression of further EC tube morphogenesis
by blockade of MT1-MMP and inhibition of tube regression
by blockade of MMP-1 and MMP-10-dependent tube
regression. Thus, MT1-MMP may be required for formation
of angiogenic vessels during the initial phases of wound
repair, while soluble MMPs such as MMP-1, -10, or murine
MMP-13 may be induced in the wound environment for
initiating regression of granulation tissue during later stages of
wound healing. The recruitment of pericytes to newly formed
vessels facilitates their stabilization and may prevent their
regression through proteinase inhibition during this process.
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